Location
Vancouver, British Columbia, Canada
Fiscal year end
December 31
AbCellera Biologics Inc. has filed 275 SEC EDGAR filings since 4/6/2017
Form type Sec Links Description Filing date Reporting date
SC 13G/A Report SC 13G/A Nov 14, 2024
SC 13G Report SC 13G Feb 14, 2024
SC 13G/A Report SC 13G/A Feb 13, 2024
SC 13G/A Report Jan 29, 2024
SC 13G/A Report SEC SCHEDULE 13G Feb 13, 2023
SC 13G/A Report SC 13G/A Feb 6, 2023
SC 13G Report Jan 18, 2023
SC 13G/A Report SC 13GA Feb 14, 2022
SC 13G/A Report SC 13G/A Feb 14, 2022
SC 13G Report SEC SCHEDULE 13G Feb 11, 2022
SC 13G/A Report SC 13G/A Feb 10, 2022
SC 13G Report SC 13G Feb 16, 2021
SC 13G/A Report AMENDMENT NO. 2 Feb 16, 2021
SC 13G Report SC 13G Feb 9, 2021
SC 13G/A Report AMENDMENT TO FORM SC 13G Dec 28, 2020
SC 13G Report ACQUISITION OF BENEFICIAL OWNERSHIP Dec 21, 2020